Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aptahem AB | 57,250 | net | 10 Sept 2021 | tx 5+57,250 |
| A1M Pharma | 46,720 | net | 28 Sept 2020 | tx 4+46,720 |
| RhoVac AB | 44,000 | net | 19 Jun 2019 | tx 3+44,000 |
| Abera Bioscience AB | 6,000 | net | 12 May 2022 | tx 1+6,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2022 | PURCHASE | Abera Bioscience AB | 6,000 | 7.98 SEK | |
| 10 Sept 2021 | OTHER | Aptahem AB | 28,500 | 0.00 SEK | deriv |
| 10 Sept 2021 | PURCHASE | Aptahem AB | 4,750 | 4.80 SEK | |
| 28 Sept 2020 | PURCHASE | A1M Pharma | 19,297 | 1.30 SEK | first after silence |
| 11 Nov 2019 | OTHER | Aptahem AB | 6,000 | 2.20 SEK | |
| 11 Nov 2019 | OTHER | Aptahem AB | 6,000 | 0.00 SEK | deriv |
| 25 Oct 2019 | OTHER | A1M Pharma | 12,188 | 1.00 SEK | |
| 25 Oct 2019 | OTHER | A1M Pharma | 12,188 | 0.00 SEK | deriv |
| 19 Jun 2019 | PURCHASE | RhoVac AB | 5,500 | 19.00 SEK | |
| 15 Apr 2019 | OTHER | Aptahem AB | 12,000 | 0.00 SEK | |
| 01 Jun 2018 | GRANT_AWARD | RhoVac AB | 5,500 | 18.00 SEK | |
| 30 May 2018 | GRANT_AWARD | RhoVac AB | 33,000 | 0.00 SEK | deriv |
| 11 Feb 2019 | PURCHASE | A1M Pharma | 3,047 | 10.20 SEK |
1 purchase reported after at least 12 months of silence — most recent on 28 Sept 2020.